501 – 510 of 744
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Glycolipid receptor depletion as an approach to specific antimicrobial therapy.
(
- Contribution to journal › Scientific review
-
Mark
Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells
(
- Contribution to journal › Article
-
Mark
Complement deficiency and disease: An update.
(
- Contribution to journal › Scientific review
-
Mark
Cobalt-mediated solid phase synthesis of 3-O-alkynylbenzyl galactosides and their evaluation as galectin inhibitors
(
- Contribution to journal › Article
-
Mark
Unfolded Protein Overload, Proteasome Activation and Death in HAMLET-Treated Tumor Cells
2006) Ubiquitin and Cancer: From Molecular Targets and Mechanisms to the Clinic In IDrugs 9(3). p.29-29(
- Contribution to journal › Published meeting abstract
-
Mark
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2005
-
Mark
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3
(
- Contribution to journal › Article
-
Mark
Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum.
(
- Contribution to journal › Article
-
Mark
Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca(2+) channels.
(
- Contribution to journal › Article
-
Mark
Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship.
(
- Contribution to journal › Article